Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach
Cancers · 26.05.2024 · 16 (11) · 2017
DOI: 10.3390/cancers16112017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.05.2024. Verfasst von BalaSubramani Gattu Linga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Women's Wellness and Research Center, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha 0974, Qatar. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As next-generation sequencing (NGS) has become more widely used, germline and rare genetic variations responsible for inherited illnesses, including cancer predisposition syndromes (CPSs) that account for up to 10% of childhood malignancies, have been found. The CPSs are a group of germline genetic disorders that have been identified as risk factors for pediatric cancer development. Excluding a few “classic” CPSs, there is no agreement regarding when and how to conduct germline genetic diagnostic studies in children with cancer due to the constant evolution of knowledge in NGS technologies. Various clinical screening tools have been suggested to aid in the identification of individuals who are at greater risk, using diverse strategies and with varied outcomes. We present here an overview of the primary clinical and molecular characteristics of various CPSs and summarize the existing clinical genomics data on the prevalence of CPSs in pediatric cancer patients. Additionally, we discuss several ethical issues, challenges, limitations, cost-effectiveness, and integration of genomic newborn screening for CPSs into a healthcare system. Furthermore, we assess the effectiveness of commonly utilized decision-support tools in identifying patients who may benefit from genetic counseling and/or direct genetic testing. This investigation highlights a tailored and systematic approach utilizing medical newborn screening tools such as the genome sequencing of high-risk newborns for CPSs, which could be a practical and cost-effective strategy in pediatric cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research, Women's Wellness and Research Center, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha 0974, Qatar.
- Translational and Precision Medicine Research, Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), Doha 0974, Qatar.
- QU Health, College of Medicine, Qatar University, Doha 0974, Qatar.
- Neonatal Intensive Care Unit (NICU), Newborn Screening Unit, Department of Pediatrics and Neonatology, Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), Doha 0974, Qatar.
- Genomics and Precision Medicine (GPM), College of Health & Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha 0974, Qatar.
- Faculty of Health and Social Care Sciences, Kingston University and St George's University of London, Kingston upon Thames, Surrey, London KT1 2EE, UK.
ORCID-Profile: BalaSubramani Gattu Linga, Sawsan G A A Mohammed, Thomas Farrell, Nader Al-Dewik, M Walid Qoronfleh
Zitieren
APA
Linga, B. G., Mohammed, S. G. A. A., Farrell, T., Rifai, H. A., Al-Dewik, N., & Qoronfleh, M. W. (2024). Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach. Cancers, 16(11), 2017. https://doi.org/10.3390/cancers16112017
Vancouver
Linga BG, Mohammed SGAA, Farrell T, Rifai HA, Al-Dewik N, Qoronfleh MW. Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach. Cancers. 2024;16(11):2017. doi:10.3390/cancers16112017
BibTeX
@article{Linga2024,
author = {Linga, BalaSubramani Gattu and Mohammed, Sawsan G A A and Farrell, Thomas and Rifai, Hilal Al and Al-Dewik, Nader and Qoronfleh, M Walid},
title = {Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach},
journal = {Cancers},
year = {2024},
volume = {16},
number = {11},
pages = {2017},
doi = {10.3390/cancers16112017}
}
EUVIMED